Connect Biopharma Holdings Ltd (CNTB) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-02

Key Insights

The reporting person, Jean I. Liu, acquired 5,061 ordinary shares of Connect Biopharma Holdings Ltd (CNTB) on March 31, 2026, in lieu of cash compensation for her role as a director.
The share acquisition was made in accordance with the company's Non-Employee Director Compensation Program, indicating the board's effort to align director compensation with shareholder interests.
The transaction represents a modest increase in the reporting person's direct ownership of CNTB shares, which could signal confidence in the company's future prospects.

Want the newest filings?

This analysis covers the filing from 2026-04-02. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-02

Insider Kleanthis Xanthopoulos acquired 2,816 ordinary shares of Connect Biopharma Holdings Ltd (CNTB) on 03/31/2026 in lieu of cash compensation, indicating his alignment with the company's long-term success.
The reported share acquisition represents a direct ownership increase of approximately 3.5% for Xanthopoulos, suggesting his confidence in the company's prospects.
This transaction was executed under the company's Non-Employee Director Compensation Program, providing transparency around the insider's incentive structure and equity-based compensation.

Filed: 2026-04-01

James Huang, a director of Connect Biopharma Holdings Ltd, has acquired 1,160,000 ordinary shares of the company at $3.45 per share, increasing his total beneficial ownership to 13,160,000 shares.
The purchase of a significant number of shares by an insider suggests Huang's confidence in the company's prospects and potential for future growth.
Investors should monitor insider trading patterns, as they can provide insights into management's views on the company's valuation and future performance.

Other reports for Connect Biopharma Holdings Ltd

Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.